Prostate Cancer Recurrence in Kidney Transplant Recipient 15 Years After Radical Prostatectomy: A Case Report.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 15 04 2019
accepted: 30 04 2019
pubmed: 15 10 2019
medline: 21 1 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

Incidence of malignant tumors in kidney transplant recipients is higher than nontransplanted population due to many factors, such as immunosuppression therapy and complex donor-recipient interaction. Genitourinary malignancies have been reported as the second most common malignancy in kidney transplant recipients. In this regard, prostate cancer is the most common neoplasm. Herein, we describe a rare case of prostate cancer recurrence after 15 years in a patient who underwent kidney transplant after radical prostatectomy.

Identifiants

pubmed: 31607619
pii: S0041-1345(19)30636-0
doi: 10.1016/j.transproceed.2019.04.098
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2995-2997

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Daniele Sforza (D)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy. Electronic address: dsforza@gmail.com.

Alessandro Parente (A)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Marco Pellicciaro (M)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Marika Morabito (M)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Giuseppe Iaria (G)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Alessandro Anselmo (A)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Elisa Rossi Lindfors (ER)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Federica Corrado (F)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Chiara Cacciatore (C)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Dario Del Fabbro (D)

Urology Unit, Department of Experimental Medicine and Surgery, Tor Vergata University of Rome, Rome, Italy.

Gianluca Ingrosso (G)

Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy Unit, Tor Vergata University of Rome, Rome, Italy.

Giuseppe Tisone (G)

Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH